seed
Stage
1
Investors
About
Inso Bio develops an automated in-solution genomic DNA sample preparation technology that reduces multi-step workflows to a single ~40 minute step. Their method is compatible with major sequencing platforms including Illumina, PacBio, and Oxford Nanopore and is targeted at scaling genomics for research and industrial use.
Explore Inso Bio's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.